-
Benserazide is a
peripherally acting aromatic L-amino acid
decarboxylase or DOPA
decarboxylase inhibitor,
which is
unable to
cross the blood–brain barrier...
- Levodopa/
benserazide, sold
under the
brand name
Prolopa among others, is a fixed-dose
combination medication used for the
treatment of Parkinson's disease...
-
synthesized benserazide, an
inhibitor of DOPA decarboxylase,
which further reduced the
required dose. A drug
combining L-DOPA with
benserazide was marketed...
- Pharmaceuticals),
Atamet (UCB),
Syndopa and
Stalevo (Orion Corporation) or with a
benserazide (combination
medicines are
branded Madopar or Prolopa), to
prevent the...
-
Examples of
extracerebral decarboxylase inhibitors include carbidopa and
benserazide.
Peripherally selective DDCIs incapable of
crossing the
protective blood–brain...
-
justifying the
prescription of d-l-5-HTP or
better with the l-5-HTP with
benserazide to
patients with
certain cerebellar ataxias including that of dyschronometria...
-
Including quality-****ured
biosimilars Trihexyphenidyl is an
alternative benserazide is an
alternative for
carbidopa Oxamniquine is
listed for use when praziquantel...
- non-Hodgkin
lymphomas and
rheumatoid arthritis. Madopar/Prolopa ([[levodopa
benserazide), for Parkinson's disease.
Mircera (methoxy
polyethylene glycol-epoetin...
-
dopamine deficiencies.
Along with carbidopa,
other DDC
inhibitors are
benserazide (Ro-4-4602), difluoromethyldopa, and α-methyldopa. Carbidopa, an inhibitor...
-
often combined with a dopa
decarboxylase inhibitor (such as
carbidopa or
benserazide).
Other agents include COMT inhibitors,
dopamine agonists, and MAO-B...
